Group items tagged

It's time for a checkup. And the patient is the Canadian healthcare system. According to Peter Adams, the healthcare system is having problems.

As stated in MaRS Press release "IDC Canada has featured MaRS client Mensante as one of its "Ten Canadian Health Companies to Watch" in 2009. Leading international psychiatrists, family physicians, psychologists, work place mental health experts and mental health economists developed an innovative web-based mental healthcare system called FeelingBetterNow(R).The College of Family Physicians of Canada has reviewed and approved FeelingBetterNow(R) as a practice management tool available to assist family physicians in patient care. The Ontario Medical Association approved the program for its members' personal use."

With Healthcare legislation well on its way to ultimate approval and implementation, the winds are now calming and its becoming clearer what the tornado has left behind for the pharmaceutical industry. Many had feared it would result in permanent widespread damage, but it appears the storm may actually have carved a path toward greener pastures for the industry.

"How can new technologies make Canada's healthcare system more efficient? BNN asks Joseph Cafazzo, Lead, Centre for Global eHealth Innovation and Peter Adams, Senior Health IT Advisor, MaRS Discovery District."

CHALLENGE: It's got potential and is ready to be built, but is the science sound? And can a fringe medical treatment have mass appeal?

Lew Lim founder of Mediclights is a MaRS client and is bringing intranasal light therapy to Canada. Peter Adams, a MaRS Life Science and Healthcare IT advisor is working with Lim to commercializing this innovation. They would like to see Toronto as the new hub for interanasal laser research.

Dr John Semple helped to created an app that is being in the healthcare industry in Canada for diagnoses. Peter Adams, senior health-care IT adviser, MaRS Discovery District, describs "Dr. Semple's app as the "tip of the iceberg," ... technology and others like it are capable of saving the health-care system millions in unnecessary hospital readmissions, needless suffering and potential deaths."

Adam Radwanski, Tim Kiladze and Tara Perkins, reports of the Globe and Mail state "Don Drummond's report caused a stir with its cost cuts and gloomy forecasts. But one positive result was that it spurred a serious examination of how to reinvent the economy." Ilse Treurnict, CEO, MaRS Discovery District,  states that the "health care sector is growing."

Segasist Technologies, a MaRS Discovery District Client, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Prostate Auto-Contouring software 'Segasist P-AC'.

MaRS Innovation and the Samuel Lunenfeld Research Institute of Mount Sinai Hospital are announce that they have entered into an agreement to collaboratively initiate commercialization of an umbilical cord stem cell technology for potential treatment in cardiovascular disease, diabetes and neurological disorders.

"The Graham Boeckh Foundation will be hosting its' first symposium, The Next Frontier in Mental Health: From Research to Patients, to discuss and provide insights on the translation of research into improved patient care and how we can move forward towards greatly improving community mental health practice in this country." The event will be held at the MaRS Centre on April 24, 2012.

According to Theresa Boyle, Health Report of The Star, states that scientists have discovered the process that underlies in the development of cancer cell mutations in breast cancer. Mike Stratton who is part of the International Cancer Genome Consortium at the MaRS Centre states these "findings will go a long way in helping the consortium achieve its goal of mapping the genetic mutations in 50 different types of cancer by 2018."

Baycrest is a provides healthcare for elderly patients and is the research centre for the development of innovation on aging and brain health. Mary Allen, report from IT in Canada states "Baycrest places a good deal of emphasis on collaboration - with the University of Toronto to meet research goals, with the MaRS Discovery District for commercialization of products to maintain healthy cognitive functioning."

Robert Lawton Burns focuses on the key role of the 'producers' as the main source of innovation in this wide-ranging analysis of business trends in the manufacturing branch of the health care industry. Written by industry academics and executives, the book provides a detailed overview of the pharmaceutical, biotechnology, genomics/proteomics, medical device and information technology sectors. Most importantly, it describes the growing convergence between these sectors and the need for executives in one sector to increasingly draw upon trends in the others.

"Encycle Therapeutics, a MaRS Innovation spin-off company, has created a ground-breaking chemistry platform for cyclizing peptides that promises to increase the efficiency of the early-stage drug discovery process."

Michael J Fox introduced his Parkinson's disease foundation at the MaRS Centre in Toronto Sept 24, 2009.